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Abstract
Background: A novel sodium fluoride toothpaste containing lactate ion and polyvinylmethylether-maleic
anhydride has been developed to promote enamel remineralisation and resistance to demineralisation. In this in
situ study, we compared this toothpaste (‘Test’) with a stannous fluoride-zinc citrate (SnF2-Zn) toothpaste
(‘Reference’) (both 1100–1150 ppm fluoride) and a fluoride-free toothpaste (‘Placebo’) using an enamel dental
erosion-rehardening model.
Methods: In each phase of this randomised, investigator-blind, crossover study, participants wore palatal appliances
holding bovine enamel specimens with erosive lesions. They brushed their natural teeth with either the Test,
Reference or Placebo toothpastes, then swished the resultant slurry. Specimens were removed at 2 h and 4 h post-
brushing and exposed to an in vitro acid challenge. Surface microhardness was measured at each stage; enamel
fluoride uptake was measured after in situ rehardening. Surface microhardness recovery, relative erosion resistance,
enamel fluoride uptake and acid resistance ratio were calculated at both timepoints.
Results: Sixty two randomised participants completed the study. Test toothpaste treatment yielded significantly
greater surface microhardness recovery, relative erosion resistance and enamel fluoride uptake values than either
Reference or Placebo toothpastes after 2 and 4 h. The acid resistance ratio value for Test toothpaste was
significantly greater than either of the other treatments after 2 h; after 4 h, it was significantly greater versus Placebo
only. No treatment-related adverse events were reported.
Conclusions: In this in situ model, the novel-formulation sodium fluoride toothpaste enhanced enamel
rehardening and overall protection against demineralisation compared with a fluoride-free toothpaste and a
marketed SnF2-Zn toothpaste.
Trial registration: ClinicalTrials.gov; NCT03296072; registered September 28, 2017.
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Background
Erosive tooth wear develops as a consequence of intra-
oral acid exposure from dietary and/or gastric sources.
Such processes can cause enamel surfaces to soften and
become more susceptible to abrasive wear or attrition,
leading to progressive loss of dental hard tissue [1, 2]. In
the initial stages of dental erosion, the enamel surface
can be rehardened by calcium and phosphate ions natur-
ally present in saliva, removing this susceptibility [3–5].
As well as having a role in preventing dental caries,
fluoride-containing toothpastes promote enamel remin-
eralisation after exposure to dietary acid, leaving a fluori-
dated surface that is more resistant to subsequent acid
exposure [6–8]. This fluoride benefit has been observed
as early as 1 h after toothpaste use in in situ experimen-
tal conditions similar to those used here, and seen to
progressively increase after 2 and 4 h [9]. Previous stud-
ies have tested the hardness of the enamel surface using
the ‘surface microhardness test’ to detect changes in
mineral content [6–10].
The most common fluoride sources for modern
toothpastes are sodium fluoride (NaF) and stannous
fluoride (SnF2), with some studies suggesting that sta-
bilised SnF2 offers greater protection against dental
erosion than other fluoride compounds [11–14]. The
formulation of a toothpaste has been shown to have
the potential to influence fluoride’s ability to protect
against dental erosion; in situ studies have indicated
that some non-fluoride ingredients in a toothpaste
formulation, such as zinc ions, sodium hexametapho-
sphate and sodium phytate, may modulate the effects
of fluoride on remineralisation–demineralisation [6,
15–17]. Previously, optimisation of the enamel protec-
tion ability of fluoride ion has been achieved by omit-
ting ingredients that either bind directly to fluoride
or interfere with fluoride binding to enamel [18]. The
Test toothpaste in this study builds on this approach
by also including polyvinylmethylether-maleic anhyd-
ride (PVM/MA) copolymer, observed to increase fluo-
ride’s ability to enhance acid resistance in vitro. It
also included sodium lactate at a pH controlled to
6.2, observed to enhance enamel fluoride uptake
(EFU) in vitro compared to a matched formulation at
near-neutral pH without lactate (data on file).
In this in situ clinical study, we aimed to determine
the ability of the Test toothpaste to enhance rehar-
dening (2 and 4 h after toothpaste treatment) of en-
amel previously softened with dietary acid; to
promote fluoride uptake to that surface; and to in-
hibit subsequent demineralisation of the rehardened
surface. The effects of this formulation were com-
pared to those of a fluoride-free (Placebo) toothpaste
and a Reference toothpaste containing 1100 ppm
fluoride as SnF2 plus zinc citrate.
Methods
We conducted a single-centre, randomised (to order in
which toothpastes were used), oral/dental examiner- and
specimen analyst-blind, three-period, three-treatment, in-
situ crossover study at the Indiana University Oral Health
Research Institute. The Indiana University Institutional
Review Board (IRB #1709160589) approved the protocol;
the study was designed according to CONSORT guidelines
and was conducted in accordance with the Declaration of
Helsinki, the International Conference on Harmonisation
of Technical Requirements for Registration of Pharmaceuti-
cals for Human Use and local laws and regulations. As the
study involved human participants, it was registered at
clinicaltrials.gov (#NCT03296072). There was one adminis-
trative change to the protocol prior to study start that did
not affect study flow or outcomes. Anonymised individual
participant data and study documents can be requested for
further research from www.clinicalstudydatarequest.com.
Experimental design: overview
This study utilised an in situ dental erosion–remineral-
isation model developed by Zero et al., [8] that has been
used in a number of similar studies [6–8, 15–17]. In
brief (Fig. 1), specimens of bovine enamel firstly under-
went an erosive challenge in vitro, then were attached to
a palatal appliance that was worn by a study participant,
and the assigned toothpaste was used as directed. The
enamel specimens were removed from the palatal appli-
ance at 2 and 4 h post-toothpaste exposure for labora-
tory assessment by the specimen analyst that included a
second in vitro erosive challenge. Further details of each
step are provided below.
Participants
Participants were recruited from an existing panel of in-
dividuals who had been pre-fitted with a maxillary pal-
atal appliance capable of housing prepared enamel
specimens. All participants were from the Indianapolis,
IN area, where community water contains approximately
0.75 ppm fluoride [19]. Eligible participants were aged 18
to 65 years, in good general and oral health and had un-
stimulated/stimulated salivary flow rates of ≥0.2 mL/min
and ≥ 0.8 mL/min, respectively. Exclusion criteria in-
cluded: presence of cavitated carious lesions (determined
by visual assessment only), moderate or severe periodon-
tal conditions, or severe tooth wear; wearing an oral ap-
pliance or orthodontia (except permanent lower
retainers); any condition that might have influenced the
study or impacted participant safety and wellbeing; preg-
nancy; breastfeeding; use of any medication that could
interfere significantly with salivary flow; an intolerance/
hypersensitivity to study materials; use of any investiga-
tional products or participation in another clinical trial
within 30 days of screening.
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Enamel specimen preparation
Bovine enamel specimens (1488 in total), taken from the
central area of the buccal surface of lower incisors (up
to two specimens per tooth), were ground-polished flat
until the enamel surfaces had a minimum 3mm× 3mm
facet in the centre. Specimens were then serially
polished with grit papers of descending coarseness, fin-
ished with a polishing cloth wetted with a 1 μm diamond
suspension then sonicated to remove any adherent pol-
ishing particles. The resulting specimens had a thickness
range of 1.7–2.2 mm.
Changes in the mineral content of the enamel speci-
mens during the experiment were evaluated using inden-
tation to determine surface microhardness (SMH) [8, 20,
21]. At baseline, five indentations 100 μm apart were
made in the centre of each enamel specimen using a
Knoop diamond under a 50 g load, applied for 11 s. Ana-
lysis of indent lengths was performed on a specimen
level and then averaged, with a participant-level average
value used for analysis.
For the first in vitro erosive challenge, enamel speci-
mens were demineralised by immersion in 35 ± 1mL
grapefruit juice (100% juice, Kroger Co, Cincinnati, OH,
USA; pH range 2.8–3.1 over the different study days)
with no stirring for 25 min, then thoroughly rinsed with
deionised water. This time period was chosen as previ-
ous studies have shown this to be an adequate amount
of time in demineralising conditions for the surface
Fig. 1 Study design
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microhardness test to detect changes without significant
surface loss (in the absence of agitation) [22]. Indenta-
tion lengths were then determined as before.
Following sterilisation with ethylene oxide, deminera-
lised enamel specimens were secured onto plastic
holders and attached to the palatal appliance, four on
each side. Following the in situ challenge period (details
below), after removal from the appliance, the specimens
underwent a second in vitro erosive challenge as above
(Fig. 1).
In situ procedure
Participants were required to complete four study visits:
screening (Visit 1), then three treatment visits (Visits 2,
3, and 4) at which each of the three treatments were
evaluated in a crossover manner. Each treatment visit
was separated by a washout period of at least 3 days that
included at least 1 day’s use of the participant’s regular
toothpaste and 2 days' use of a non-fluoridated (non-
marketed) toothpaste immediately prior to the visit
using a provided toothbrush (Oral-B® Sensi Soft Manual;
Procter & Gamble Company, Cincinnati, OH, USA). At
Visit 1, participants gave written informed consent to
take part in the study and their demographics, medical
history and prior medications were recorded. Oral hard
tissue (OHT) and oral soft tissue (OST) examinations
were performed, followed by saliva flow rate assessment.
Eligible participants had their palatal appliance assessed
for comfort, with new appliances made for those whose
appliance no longer fitted adequately.
At Visits 2, 3, and 4, participants underwent a pre-
treatment OST examination, then the study investiga-
tor (the oral/dental examiner) placed the palatal ap-
pliance holding the eight pre-demineralised bovine
tooth enamel specimens in the participant’s mouth.
An equilibration period of at least 5 min was given to
allow for development of a salivary pellicle on the en-
amel blocks.
Participants received the study treatments detailed in
Table 1 in a predetermined order according to a ran-
domisation schedule generated by a contracted statistical
analysis organisation using a Williams Square design
balanced for first period carryover. Study numbers were
allocated in ascending order as each participant was en-
tered into the trial.
The oral/dental examiner and the specimen analyst
were not permitted in the room where study products
were dispensed. The oral/dental examiner, specimen
analyst, study statistician and any relevant study sponsor
or research centre employees were blinded to treatment
received. While treatment group was not revealed to the
participant during the study and the study toothpastes
were supplied to the study site in over-wrapped tubes to
conceal product identity, participants could not be
deemed fully blinded as, according to ICH guidelines,
for a truly double blind study, the products would need
to be identical in every way, including taste and texture,
which they were not.
At each study visit, following the equilibration period,
the participant was provided with a new toothbrush (as
above) loaded with 1.5 g of the assigned toothpaste. The
participant brushed the buccal surfaces of their natural
teeth only for 25 timed seconds and then swished the
resulting toothpaste slurry around their mouth for 95 s.
After expectorating the slurry, the participant gently
rinsed their mouth with 15 mL tap water for 10 s before
expectorating again.
After completing the brushing/rinsing procedures, par-
ticipants continued to wear their palatal appliance for a
total of 4 h. Enamel specimens were removed in a prede-
termined order from the appliance at 2 and 4 h (four at
each timepoint). Once the appliance was removed from
the participant’s mouth after 4 h, a post-treatment OST
examination was performed.
Safety
Adverse events (AEs) and any abnormalities in the OHT
or OST examinations were recorded from the end of
screening until 5 days after the last administration of
study product. Clinical judgement was exercised by the
oral/dental examiner to diagnose the AE and to assess
the relationship between the study product and occur-
rence of each AE, with intensity graded as mild, moder-
ate, or severe.
Specimen analysis
Indentation lengths (details above) were determined
prior to (B) and after (E1) the first in vitro erosive chal-
lenge, after the treatment-induced in situ rehardening
phase (R), and after the second in vitro erosive challenge
(E2) (Fig. 1). The extent of rehardening was calculated
as SMH recovery (SMHR) where %SMHR = {(E1-R)/(E1-
B)}*100 [23]. Overall resistance of treated enamel to the
erosive challenge was calculated as relative erosion re-
sistance (RER), where %RER = {(E1-E2)/(E1-B)}*100 [24].
Acid resistance following intra-oral rehardening after
treatment with the study toothpastes was calculated as
Table 1 Study treatments
Toothpaste group Relevant formulation ingredients
Test toothpaste 0.254% w/w NaF (1150 ppm fluoride),
5% KNO3, PVM/MA copolymer, sodium
lactate, pH 6.2
Placebo toothpaste 5% KNO3, PVM/MA copolymer, sodium
lactate (0 ppm fluoride)
Reference toothpastea 0.454% w/w SnF2 (1100 ppm fluoride),
zinc citrate (‘SnF2-Zn’)
aCrest® Pro-Health Sensitivity and Enamel Shield (Smooth Formula); Procter &
Gamble Company, Cincinnati, OH, USA; US-marketed product
Creeth et al. BMC Oral Health          (2020) 20:118 Page 4 of 10
the acid resistance ratio (ARR) where ARR = 1-{(E2-R)/
(E1-B)} [7].
EFU was assessed by microdrill enamel biopsy after
the in situ rehardening period, before the second ero-
sive challenge [25]. Enamel specimens were drilled to
a depth of 100 μm through the entire lesion, with
four cores obtained per specimen. The enamel pow-
der sample pooled from the four cores was dissolved
in perchloric acid (20 μl of 0.5 M HClO4) then
buffered with a citrate/ethylenediaminetetraacetic acid
solution prior to analysis via a pre-calibrated fluoride-
specific electrode. The diameter of the drilled cores
was measured via light microscopy and the EFU
expressed as amount of fluoride divided by the com-
bined area of the enamel cores (μg F/cm2). These
values were averaged across the four enamel speci-
mens evaluated at each timepoint to produce the
participant-wise mean EFU.
Statistical analysis
Sufficient participants were screened so that up to 66
could be randomised to treatment, aiming to ensure that
60 evaluable participants completed the study. This sam-
ple was calculated to have 90% power to detect a differ-
ence in mean %SMHR of 5.0 between study products at
4 h, assuming a standard deviation (SD) of differences of
11.92 (from a previous, unpublished study, data on file),
using a paired t-test with a 0.05 two-sided significance
level. This sample size was calculated to have 80% power
to detect a difference in %RER of 7.4 between study prod-
ucts. While these specific calculations were based on an
unpublished study, participant numbers are similar to or
higher than a number of previous in situ erosion-
remineralisation model studies [6, 7, 11–13, 16, 20].
Efficacy analyses were conducted on a modified intent-
to-treat (mITT) population, defined as all participants
who were randomised into the study, received at least
one dose of study product and had at least one post-
baseline efficacy assessment. The safety population in-
cluded all randomised participants who received at least
one dose of study product.
The primary efficacy endpoint was the difference be-
tween the Test and Placebo toothpastes in %SMHR after
4 h of intraoral exposure. The difference was required to
be statistically significant (p < 0.05) to meet the success
criteria of the study. Secondary efficacy endpoints in-
cluded the differences in %RER and EFU between the
Test and Placebo toothpastes and in all measures
between the Test and Reference toothpastes after 4 h.
Exploratory endpoints included the difference in all
measures for all paired efficacy comparisons after 2 h.
Post-hoc analyses were comparison of ARR values be-
tween all treatments at both timepoints, and all other
paired efficacy comparisons for each endpoint
between the Placebo and Reference toothpastes at
both timepoints.
Statistical analyses for all endpoints were performed
using a mixed model analysis of variance (ANOVA)
model that included fixed factors for study period and
treatment and a random effect for participant. Statistical
testing of all endpoints in this study was conducted at a
two-sided significance level of 0.05. As a primary object-
ive was defined prior to analysis, there was no adjust-
ment for multiple comparisons. Adjusted means of all
treatments and treatment differences were provided to-
gether with their standard error (SE), 95% confidence in-
tervals (CIs) and p-values.
Results
The first participant was enrolled on November 13,
2017; the last participant completed the study on Janu-
ary 16, 2018. Of the 68 participants screened, 62 were
randomised to treatment and completed the study. All
randomised participants were included in the mITT and
safety populations. The majority of participants were fe-
male (n = 45; 72.6%) and were of White/Caucasian/Euro-
pean heritage (n = 42; 67.7%), with 14 (22.6%) of African
American/African heritage, and six (9.7%) of Asian heri-
tage or multiple races. Overall mean age was 43.4 (SD
13.38) years, with a range of 20 to 65 years.
Efficacy
Enamel microhardness mean indentation lengths as a
function of treatment, stage of the experiment and dur-
ation of rehardening are shown in Table 2. Figures for
each efficacy endpoint (%SMHR, %RER, EFU, ARR) re-
flect raw mean values following the respective analysis
detailed in the Methods section. Table 3 details the dif-
ference between the adjusted mean values (from the
ANOVA model) of each toothpaste group and provides
statistical analysis regarding the significance of these
differences.
Surface microhardness recovery
Raw mean %SMHR (±SE) is shown in Fig. 2. After 2 and
4 h, the adjusted mean %SMHR was statistically signifi-
cantly greater for the Test toothpaste than for either the
Placebo or Reference toothpastes (Table 3). The signifi-
cant difference after 4 h met the pre-designated primary
objective of the study. Post-hoc analysis showed no
statistically significant differences between Placebo and
Reference toothpastes at either timepoint (Table 3).
Relative erosion resistance
Raw mean %RER (±SE) is shown in Fig. 3. After 2 and
4 h, the adjusted mean %RER was statistically signifi-
cantly greater (less negative) for the Test toothpaste than
for either the Placebo or Reference toothpastes (Table
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3). Post-hoc analysis showed that the %RER for the Ref-
erence toothpaste was superior to the Placebo toothpaste
at both timepoints (Table 3).
Enamel fluoride uptake
Mean EFU (±SE) is shown in Fig. 4. After 2 and 4 h, the
adjusted mean EFU was statistically significantly greater
for the Test toothpaste than for either the Placebo or Ref-
erence toothpastes (Table 3). Post-hoc analysis showed
that the EFU for the Reference toothpaste was superior to
the Placebo toothpaste at both timepoints (Table 3).
Acid resistance ratio
Mean ARR (±SE) is shown in Fig. 5. Post-hoc analysis
showed that after 2 and 4 h, adjusted mean ARR was sta-
tistically significantly greater for the Test than for the
Placebo toothpaste (Table 3). The ARR value for the
Test toothpaste was statistically significantly greater than
the Reference toothpaste at 2 h, but the difference was
not significant at 4 h. Post-hoc analysis showed that the
ARR for the Reference toothpaste was superior to the
Placebo toothpaste at both timepoints (Table 3).
Safety
Twenty-one participants (33.9%) reported at least one
treatment-emergent adverse event (TEAE), with 26
TEAEs in total. Twelve participants (19.4%) reported at
least one oral TEAE (a total of 14 oral TEAEs), in
roughly equal numbers across groups. Ten participants
(16.1%) reporting at least one non-oral TEAE (12 TEAEs
in total). All TEAEs were of mild or moderate intensity,
resolved by study completion and did not lead to with-
drawal from the study; none was considered treatment-
related. There were no serious AEs reported during the
study.
Discussion
Measuring enamel erosion in vivo is technically very
challenging. Changes occur on a micrometre scale (un-
less timescales are very long) on complex dental surfaces
without stable reference points [2]. Studies with in situ
models are therefore widely accepted as the current
industry-standard approach to assessing treatment ef-
fects on acid erosion processes. This approach does have
the limitation that such models cannot fully mimic the
clinical situation; however, because enamel surfaces for
in situ studies can be prepared in advance and changes
measured outside of the mouth while treatment and re-
mineralisation occur in the mouth, measurements are
relatively precise, control of treatment conditions is high,
and measurable changes can occur on short time-scales
[3, 6–8, 11–17, 20, 21, 23, 24].
The present in situ model was designed to monitor
erosive demineralisation and remineralisation processes
representing typical daily behaviour. Many individuals
consume an acidic beverage at breakfast, such as or-
ange or grapefruit juice, which may soften the enamel
surface (first stage of dental erosion). They may then
brush with a fluoridated toothpaste, which supplies
fluoride for several hours to enhance saliva-mediated
Table 2 Enamel microhardness mean indentation lengths [μm (±SE)] (mITT population, n = 62)
Time point Treatment Baseline [B] After first demineralisation [E1] After intraoral exposure [R] After second demineralisation [E2]
2 h Test 43.4 (0.1) 59.7 (0.2) 55.8 (0.3) 64.8 (0.3)
Reference 43.4 (0.1) 59.8 (0.1) 56.5 (0.2) 66.9 (0.3)
Placebo 43.4 (0.1) 60.0 (0.2) 56.9 (0.2) 71.0 (0.5)
4 h Test 43.3 (0.1) 59.8 (0.2) 54.9 (0.3) 63.7 (0.3)
Reference 43.3 (0.1) 59.8 (0.2) 56.2 (0.2) 65.5 (0.4)
Placebo 43.4 (0.1) 59.8 (0.2) 56.1 (0.2) 68.9 (0.5)
Table 3 Differences between treatments at 2 and 4 h post-treatment (mITT population; n = 62)
Time- point Treatment
comparison
Differences between treatments (adjusted mean with 95% CI); p-valuea,b
%SMHR %RER EFU (μg F/cm2) ARR
2 h Test vs Placebo 5.62 (2.80, 8.43) 0.0001 36.41 (31.65, 41.18) < 0.0001 1.65 (1.41, 1.88) < 0.0001 0.31 (0.26, 0.35) < 0.0001
Test vs Ref 3.90 (1.09, 6.72) 0.0070 12.60 (7.84, 17.36) < 0.0001 0.95 (0.72, 1.19) < 0.0001 0.09 (0.04, 0.13) 0.0002
Ref vs Placebo 1.71 (−1.10, 4.53) 0.2303 23.8 (19.05, 28.58) < 0.0001 0.69 (0.46, 0.93) < 0.0001 0.22 (0.18, 0.27) < 0.0001
4 h Test vs Placebo 7.69 (5.18 10.19) < 0.0001 33.29 (28.89, 37.68) < 0.0001 1.81 (1.59, 2.04) < 0.0001 0.26 (0.21, 0.30) < 0.0001
Test vs Ref 7.57 (5.07, 10.07) < 0.0001 10.98 (6.58, 15.37) < 0.0001 0.97 (0.75, 1.20) < 0.0001 0.03 (−0.01, 0.08) 0.1071
Ref vs Placebo 0.12 (−2.38, 2.62) 0.9259 22.3 (17.92, 26.70) < 0.0001 0.84 (0.62, 1.06) < 0.0001 0.22 (0.18, 0.26) < 0.0001
aFrom ANOVA model with fixed factors for study period and treatment, and a random effect for participant.
bDifference is first-named treatment minus second-named treatment, a positive difference favours first-named treatment.
Statistically significant comparisons are highlighted in bold.
Ref: Reference toothpaste.
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rehardening of the softened enamel. This may be
followed by an additional dietary erosive challenge
from an acidic drink some hours later. The aim of
the model is therefore to mimic such a scenario,
modelling the very earliest stages of erosive deminer-
alisation, followed by fluoride-enhanced rehardening
and a subsequent acid challenge.
In the present study, our results clearly showed that
the Test toothpaste – containing NaF – outperformed
the Reference toothpaste – containing SnF2 and zinc cit-
rate – and the fluoride-free Placebo toothpaste in terms
of enamel rehardening. They also showed that the NaF
Test toothpaste provided superior overall protection of
the enamel surface through a cycle of treatment-induced
rehardening and acid-induced demineralisation (RER).
The specific measure of enamel acid resistance post-
rehardening, ARR, showed superiority of the NaF tooth-
paste at the 2 h timepoint; this difference was no longer
statistically significant at the 4 h timepoint (p = 0.1071).
It seems that the high acid resistance after rehardening
(relative to before treatment) for the Test toothpaste
group is due primarily to the high level of fluoride
Fig. 2 Raw mean (±SE) percent surface microhardness recovery (%SMHR) by treatment group (mITT population). Higher values are favourable
Fig. 3 Raw mean (±SE) percent relative erosion resistance (%RER) by treatment group (mITT population). Higher (less negative) values
are favourable
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incorporated into the newly-formed mineral. The super-
ior EFU of the Test toothpaste treatment compared to
the other two treatments supports these differences in
mineralisation measures.
The low uptake of fluoride from the reference SnF2-
Zn toothpaste, and absence of rehardening over-and-
above the placebo in this type of model, is consistent
with in vitro observations that stannous ions can inhibit
enamel remineralisation [26, 27]. The relatively high re-
sistance to acid, in spite of the low fluoride uptake, also
suggests stannous ions inhibited enamel demineralisa-
tion, in addition to the inhibition provided by fluoride in
this study [11–14].
The modes of action of the key extra ingredients of
the NaF formulation, i.e., lactate ion and PVM/MA
copolymer at pH 6.2, are not yet fully understood.
Certain carboxylic acid polymers have been shown
in vitro to enhance resistance to demineralisation
[28]. It is assumed that multi-point attachment of
polycarboxylic acid polymer chains, such as PVM/
MA, tends to stabilise the surface against demineral-
isation challenges. Reducing pH from the neutral
range typical of conventional dentifrices is well-
established to increase EFU from fluoride products
in vitro [29, 30]. At pH 6.2, in the presence of lactate
ion, higher EFU has been observed in vitro compared
to a neutral, lactate-free equivalent formulation (data
on file). It should be noted that specific effects of
these agents in a clinical situation have yet to be
demonstrated.
Fig. 4 Raw mean (±SE) enamel fluoride uptake (EFU) by treatment group (mITT population). Higher values are favourable
Fig. 5 Raw mean (±SE) acid resistance ratio (ARR) by treatment group (mITT population). Higher values are favourable
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Conclusion
Within the limitations imposed by this short-term, in
situ dental erosion rehardening model, a NaF dentifrice
containing PVM/MA copolymer and lactate ion at pH
6.2 provided enhanced enamel rehardening and greater
overall protection from subsequent in vitro enamel de-
mineralisation, compared with a fluoride-free toothpaste
and a marketed anti-erosion toothpaste. While the per-
formance of the novel Test dentifrice in this model has
been demonstrated, the mode of action of the ingredi-
ents in the formulation have not been established and
this area warrants further research.
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